26.11.2012 Views

Peptide-Based Drug Design

Peptide-Based Drug Design

Peptide-Based Drug Design

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Analysis of Aβ Interactions 73<br />

are then converted into mature fibrils, which adopt cross-�-pleated sheets (9)<br />

and eventually fibrils (10). Interestingly, it is the intermediate products, rather<br />

than the mature fibrils that have been shown to be the most neurotoxic (8,10,11).<br />

The mechanisms by which A� induce toxicity include (1) oxidative stress<br />

(12), (2) direct disruption of membrane integrity (13), and(3) alteration in<br />

Ca 2+ homeostasis (14). Oxidative stress is initiated by binding interactions<br />

between A� and metal ions (Cu 2+ ,Fe 3+ ) via histidine residues 6, 13, and 14<br />

(15). This interaction leads to the reduction in the oxidation state of metal<br />

ions and generation of H2O2 with the subsequent generation of free radicals<br />

that induce oxidative damage, including lipid peroxidation and the subsequent<br />

disruption of the cellular membrane. Methionine 35 (Met35) of A� is also<br />

thought to play a critical role since oxidized Met35 A� products have been<br />

found in postmortem AD plaques (16). Furthermore, peptides lacking Met35<br />

have a decreased capacity to reduce Cu 2+ and generate H2O2 (17). A� has<br />

also been demonstrated to directly interact with membrane lipids to form cation<br />

selective channels (18). It is thought that these channels disrupt ion homeostasis<br />

(18), leading to an accumulation of intracellular Ca 2+ levels and the subsequent<br />

induction of apoptosis (19).<br />

The study of A� and the mechanisms described, including (1) production<br />

of toxic A� fragments, (2) generation of aggregates, and (3) interactions<br />

with membranes is essential to further understand the pathology of disease.<br />

ProteinChip R○ technology is a method that facilitates the analysis of all these<br />

processes. Information acquired from such analysis will not only help to further<br />

elucidate the precise role of A� in AD, but may have wider implications for<br />

the development of an anti-A� therapeutic that blocks the toxic effects of the<br />

molecule. Furthermore, this technology provides a valuable means to assess the<br />

effectiveness of therapeutic intervention. This chapter will describe ProteinChip<br />

technology, its advantages over traditional techniques, and how it can be used<br />

for the analysis of the mechanisms described.<br />

1.2. ProteinChip Technology<br />

ProteinChip technology employs surface enhanced laser desorption/<br />

ionization time-of-flight mass spectrometry (SELDI-TOF MS), which combines<br />

two well-established methods of solid phase chromatography and TOF-MS into<br />

an integrated platform (20). The proprietary ProteinChip arrays distinguish this<br />

technology from other MS-based systems. The arrays possess chromatographic<br />

surfaces including hydrophobic, hydrophilic, anion exchange, cation exchange,<br />

and immobilized-metal affinity and are utilized to enrich for subsets of the<br />

proteome with common biochemical properties. Furthermore, we have adapted<br />

this technology to create a synthetic solid phase membrane layer on the array

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!